Skip to content

SNY

Sanofi

NASDAQ · Healthcare · Drug Manufacturers - General · FR

$42.48
−1.53%
Ask drillr

Next report

Analyst consensus

Next report date
Oct 30, 2026
EPS estimate
$1.73
Revenue estimate
$15.4B

Latest reported

Last report date
Jul 30, 2026
EPS actual
$1.21
EPS estimate
$1.10
Revenue actual
$14.1B
Revenue estimate
$13.1B

Track record

Trailing twelve quarters

EPS beats (12Q)
9
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
+6.7%
Revenue beats (12Q)
7
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Jul 30, 2026$1.10$1.21Beat 10.20%$14.1B
Apr 23, 2026$1.06$1.10Beat 3.87%$12.9B
Jan 29, 2026$0.84$0.89Beat 6.33%$14.3B
Oct 24, 2025$1.60$1.70Beat 6.32%$15.4B
Jul 31, 2025$0.96$0.90Miss -6.15%$12.6B
Apr 24, 2025$0.90$0.94Beat 4.44%$11.6B
Jan 30, 2025$0.71$0.70Miss -1.96%$7.9B
Oct 25, 2024$1.35$1.57Beat 16.38%$15.5B
Jul 25, 2024$0.86$0.93Beat 8.01%$12.2B
Apr 25, 2024$0.94$0.97Beat 2.65%$11.9B
Feb 1, 2024$0.94$0.89Miss -5.22%$25.2B
Oct 27, 2023$1.37$1.39Beat 1.16%$13.4B

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026